Capricor Therapeutics
CAPR
#5195
Rank
S$2.13 B
Marketcap
S$36.87
Share price
-2.40%
Change (1 day)
173.85%
Change (1 year)

Earnings for Capricor Therapeutics (CAPR)

Earnings in 2025 (TTM): -S$0.14 Billion

According to Capricor Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2024 earnings that were of -S$51.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Capricor Therapeutics from 2001 to 2025

Annual earnings

Year Earnings Change
2025 -S$0.14 Billion159.57%
2024 -S$51.69 Million81.57%
2023 -S$28.47 Million-23.2%
2022 -S$37.07 Million44.93%
2021 -S$25.58 Million46.61%
2020 -S$17.45 Million78.71%
2019 -S$9.76 Million-49.7%
2018 -S$19.41 Million-724.78%
2017 S$3.1 M-112.93%
2016 -S$24.02 Million46.27%
2015 -S$16.43 Million106.82%
2014 -S$7.94 Million-48.41%
2013 -S$15.39 Million977.23%
2012 -S$1.43 Million-77.11%
2011 -S$6.25 Million-22.35%
2010 -S$8.04 Million-20.17%
2009 -S$10.07 Million-41.17%
2008 -S$17.12 Million41.05%
2007 -S$12.14 Million1098.87%
2006 -S$1.02 Million4101.55%
2005 -S$0.03 Million-0.97%
2004 -S$0.03 Million17.87%
2003 -S$0.03 Million3.66%
2002 -S$0.02 Million-30.11%
2001 -S$0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.17 B-24,832.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$1.02 B-860.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-S$1.06 Billion 689.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.37 Billion 173.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-S$6.13 Million-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-S$12.12 Million-90.97%๐Ÿ‡บ๐Ÿ‡ธ USA